Completed PHASE4 INTERVENTIONAL 1-arm NCT05474716

The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA

The Effect of Topical Brimonidine on the Hemodynamics of the Optic Nerve Head and Retinochoroidal Circulation in Patients of Primary Open Angle Glaucoma Using Optical Coherence Tomography Angiography

Sponsor: Fayoum University

Conditions Glaucoma, Primary Open Angle Ocular Blood Flow Optical Coherence Tomography Angiography

Interventions Brimonidine tartrate 0.2% ophthalmic solution

Updated 4 times since 2022 Last updated: Jul 23, 2022 Started: May 1, 2020 Primary completion: Dec 1, 2021 Completion: Jul 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Glaucoma, Primary Open Angle and Ocular Blood Flow, this trial is completed. The trial is conducted by Fayoum University and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2022 — Jul 2024 [monthly]

Completed PHASE4

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fayoum University

Data source: Fayoum University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Fayyum, Egypt